Clinical Trials
10 trialsNCT05193721 2024-03-20
A Clinical Study of the Safety and Tolerability of SHR-1901 in Subjects With Advanced Malignant Tumors
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1 Unknown
NCT05396391 2023-07-20
A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors
SUNHO（China）BioPharmaceutical CO., Ltd.
Phase 1/2 Unknown
NCT04980690 2023-03-10
Clinical Trial of IBC0966 in Patients With Advanced Malignant Tumors
SUNHO（China）BioPharmaceutical CO., Ltd.
Phase 1/2 Unknown
NCT05728541 2023-02-17
Dose Escalation and Expansion Study of SYH2043 in Patients With Advanced Malignant Tumors
CSPC Ouyi Pharmaceutical Co., Ltd.
Phase 1 Unknown
NCT04708210 2022-10-12
Study of the Efficacy and Safety of IBI319 in Patients With Advanced Malignant Tumors
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1 Unknown
NCT05235542 2022-08-11
A Phase Ib/II Study of AK104 and AK117 in Combination With or Without Chemotherapy in Advanced Malignant Tumors
Akeso
Phase 1/2 Unknown
NCT05198817 2022-06-28
A Trial of SHR-2002 Injection or Combined With Other Anti-cancer Medication in Advanced Malignant Tumors of Patients
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1 Unknown
NCT05354076 2022-04-29
Study on the Correlation Between Immunoglobulin and Liposomal Doxorubicin in Vivo
Fudan University
Phase 2 Unknown
NCT05110807 2022-02-14
A Clinical Study to Evaluate the Tolerability and Pharmacokinetics of TQB3617 Capsule in Patients With Advanced Malignant Tumors
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Unknown
NCT04128085 2019-12-16
A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3804 in Subjects With Advanced Malignant Tumors
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Unknown